Texas Permanent School Fund’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-364,872
Closed -$66.4M 11
2024
Q1
$66.4M Buy
364,872
+423
+0.1% +$72.9K 0.52% 23
2023
Q4
$56.5M Sell
364,449
-172
-0% -$25.1K 0.49% 23
2023
Q3
$54.4M Sell
364,621
-4,854
-1% -$713K 0.53% 21
2023
Q2
$49.8M Buy
369,475
+1,177
+0.3% +$173K 0.46% 25
2023
Q1
$58.7M Buy
368,298
+117,032
+47% +$17.9M 0.58% 20
2022
Q4
$40.6M Buy
251,266
+1,092
+0.4% +$167K 0.62% 20
2022
Q3
$33.6M Buy
250,174
+16,765
+7% +$2.41M 0.54% 21
2022
Q2
$35.7M Buy
233,409
+4,100
+2% +$626K 0.57% 20
2022
Q1
$37.2M Sell
229,309
-14,179
-6% -$2.06M 0.51% 21
2021
Q4
$33M Sell
243,488
-29,510
-11% -$3.49M 0.4% 31
2021
Q3
$29.4M Sell
272,998
-20,420
-7% -$2.33M 0.36% 40
2021
Q2
$33.1M Sell
293,418
-1,448
-0.5% -$163K 0.38% 34
2021
Q1
$31.9M Sell
294,866
-16,409
-5% -$1.76M 0.39% 35
2020
Q4
$33.4M Sell
311,275
-20,514
-6% -$1.97M 0.42% 33
2020
Q3
$29.1M Buy
331,789
+21,244
+7% +$2M 0.39% 37
2020
Q2
$30.5M Buy
310,545
+53,006
+21% +$4.67M 0.48% 30
2020
Q1
$19.6M Sell
257,539
-4,134
-2% -$352K 0.36% 46
2019
Q4
$23.2M Sell
261,673
-13,730
-5% -$1.14M 0.35% 43
2019
Q3
$20.9M Sell
275,403
-9,694
-3% -$665K 0.33% 51
2019
Q2
$20.7M Sell
285,097
-1,871
-0.7% -$147K 0.32% 51
2019
Q1
$23.1M Sell
286,968
-15,585
-5% -$1.27M 0.37% 46
2018
Q4
$27.9M Sell
302,553
-37,384
-11% -$3.29M 0.49% 30
2018
Q3
$32.2M Sell
339,937
-29,876
-8% -$2.83M 0.44% 35
2018
Q2
$34.3M Sell
369,813
-42,067
-10% -$4.11M 0.47% 34
2018
Q1
$39M Sell
411,880
-23,292
-5% -$2.56M 0.52% 31
2017
Q4
$42.1M Sell
435,172
-6,600
-1% -$622K 0.53% 31
2017
Q3
$39.3M Sell
441,772
-5,402
-1% -$411K 0.5% 33
2017
Q2
$32.4M Sell
447,174
-18,541
-4% -$1.25M 0.43% 38
2017
Q1
$30.3M Sell
465,715
-21,104
-4% -$1.33M 0.4% 41
2016
Q4
$30.5M Sell
486,819
-14,717
-3% -$898K 0.41% 38
2016
Q3
$31.6M Sell
501,536
-23,203
-4% -$1.5M 0.42% 40
2016
Q2
$32.5M Sell
524,739
-31,352
-6% -$1.91M 0.43% 43
2016
Q1
$31.8M Sell
556,091
-22,543
-4% -$1.26M 0.4% 44
2015
Q4
$34.3M Sell
578,634
-11,623
-2% -$669K 0.42% 41
2015
Q3
$32.1M Sell
590,257
-35,791
-6% -$2.33M 0.41% 41
2015
Q2
$42.1M Buy
626,048
+29,336
+5% +$1.92M 0.49% 36
2015
Q1
$34.9M Sell
596,712
-9,140
-2% -$552K 0.39% 48
2014
Q4
$39.6M Sell
605,852
-12,337
-2% -$778K 0.44% 39
2014
Q3
$35.7M Sell
618,189
-44,704
-7% -$2.48M 0.4% 40
2014
Q2
$37.4M Sell
662,893
-34,172
-5% -$1.79M 0.39% 39
2014
Q1
$35.8M Sell
697,065
-39,550
-5% -$2M 0.37% 45
2013
Q4
$38.9M Sell
736,615
-52,183
-7% -$2.56M 0.39% 44
2013
Q3
$35.3M Sell
788,798
-23,844
-3% -$1.06M 0.36% 45
2013
Q2
$33.6M Buy
+812,642
New +$35.5M 0.35% 49

Other funds holding ABBV

Texas Permanent School Fund's ABBV Position: Q2 2024 in Review

Texas Permanent School Fund sold out of AbbVie (ABBV) in Q2 2024, closing a stake of 364,872 shares — an estimated $66.4M sold.

Texas Permanent School Fund first reported a position in ABBV in Q2 2013 and held it in 44 quarters. The position peaked at $66.4M in Q1 2024. 3,364 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

  • Texas Permanent School Fund reported no remaining AbbVie position as of Q2 2024 after selling out during the quarter.
  • Texas Permanent School Fund sold 364,872 AbbVie shares in Q2 2024, an estimated $66.4M.
  • Texas Permanent School Fund first reported a position in AbbVie in Q2 2013 and held it in 44 quarters.
  • Texas Permanent School Fund's AbbVie position peaked at $66.4M in Q1 2024.
  • 3,364 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on Texas Permanent School Fund's 13F filing for Q2 2024, filed 7 Aug 2024.